Xonvea – side effect profile1
Xonvea contains the most studied drug combination in pregnancy, designed specifically for NVP, with over 33,000,000 prescriptions between 1956-1983,2,10 40 years of data in pregnant women and 2 meta-analyses involving data from more than 200,000 pregnancies.2-5
There has been vast clinical experience regarding the use of the Xonvea combination (doxylamine/pyridoxine combination) use in pregnancy dating back to 1956.1,2
Adverse events include:1
- Nervous system disorders: somnolence (very common); dizziness (common)
- Gastrointestinal disorders: dry mouth (common)
- General disorders and administration site conditions: fatigue (common).
Please read the product’s prescribing information for a full list of the adverse events for this medication and refer to the Summary of Product characteristics before prescribing. Click here for prescribing information and adverse events reporting.
You can also visit our safety and historical use page for more information.